Pediatric Rare Disease Trials Under EU Regulation
Pediatric Rare Disease Trials Under EU Regulation Conducting Pediatric Rare Disease Trials in the EU: Regulatory Insights Pediatric rare disease trials present unique regulatory and operational challenges in the European Union (EU). With over 6,000 identified rare diseases, most affecting children, there is an urgent need for innovative clinical development pathways. The EU Pediatric Regulation…
Read More “Pediatric Rare Disease Trials Under EU Regulation” »